BashTheBug reaches one million classifications Philip Fowler, 4th October 20184th October 2018 BashTheBug, a citizen science project I run that is helping us measure how different clinical samples of M. tuberculosis grow in the presence of 14 different antibiotics, reached its first million classifications earlier this week. To read more head over to its blog. The photo mosaic on the left is made up of images sent in by volunteers who’ve all contributed to the success of BashTheBug. Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related antimicrobial resistance citizen science clinical microbiology tuberculosis
tuberculosis Kafka and tuberculosis 21st June 20241st July 2024 To mark the centenary of Franz Kafka’s death from laryngeal tuberculosis at the age of… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
New preprint: ONT sequencing is comparable to Illumina sequencing for M. tuberculosis 9th April 20269th April 2026 In this preprint, we compare the differences when Mycobacterial samples are sequenced with either long-… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
New preprint: evaluating a laboratory workflow for sequencing Mycobacteria using long-read sequencing 7th February 20269th April 2026 In this preprint, we describe and evaluate a laboratory workflow for sequencing Mycobacterial samples using… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More